Bio-Techne Corporation

Laboratory and Research Supplies and Equipment

New miRNAscope Assay Detects Ultra-Short Molecules in Native Tissue

Utilizes signal amplification and background suppression technology to deliver researchers with elevated specificity, sensitivity and high signal-to-noise detection. Enables in-situ detection of short nucleic acid targets between 17-50 nucleotides which includes microRNAs, RNAs (siRNAs) and antisense oligonucleotides (ASOs). Offers RNAscope technology for spatial visualization of single-molecule...

Read More »
Health, Medical, & Dental Supplies and Equipment

Bio-Techne's New Exosome-based Liquid Biopsies Helping to Advance Personalized Care in Lung Cancer Diagnostics

Minneapolis, May 28, 2019 /PRNewswire/ -- Bio-Techne today announced the publication of a recent validation study demonstrating that the proprietary exosome-based liquid biopsy tests from Bio-Techne's Exosome Diagnostics brand may be used to assess the mutational status of the Epidermal Growth Factor Receptor (EGFR) gene in patients with non-small cell lung cancer (NSCLC). The data from...

Read More »
Company News

Bio-Techne Announces Opening of New Canadian Facility

Minneapolis, Oct. 1, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced the opening of its new Canadian office located in Toronto. This new office will be the workplace for approximately 40 Bio-Techne employees and reflects the Company's commitment to supporting the Canadian life sciences industry as well as expectations for continued growth in this geography....

Read More »
Laboratory and Research Supplies and Equipment

New miRNAscope Assay Detects Ultra-Short Molecules in Native Tissue

Utilizes signal amplification and background suppression technology to deliver researchers with elevated specificity, sensitivity and high signal-to-noise detection. Enables in-situ detection of short nucleic acid targets between 17-50 nucleotides which includes microRNAs, RNAs (siRNAs) and antisense oligonucleotides (ASOs). Offers RNAscope technology for spatial visualization of single-molecule...

Read More »
Company News

Bio-Techne Attains ISO 9001:2015 Certification for Fetal Bovine Serum Manufacturing Facility

MINNEAPOLIS, Sept. 16, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it has attained ISO 9001:2015 certification at its fetal bovine serum (FBS) and specialty media manufacturing facility in Flowery Branch, Georgia. ISO 9001:2015 is an international Business Quality Management System standard that is recognized globally as an indicator of quality excellence....

Read More »
Company News

Bio-Techne China Recognized with Decade of Contribution Award

MINNEAPOLIS, June 26, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) was recently honored with the "Decade of Contribution Award" at the 2019 (10th) International Conference on Cell Therapy conference. This award recognized the commitment of Bio-Techne's team in China to providing comprehensive support and reliable products and services for the Chinese Biotechnology...

Read More »
Mergers & Acquisitions

Bio-Techne to Acquire B-MoGen Biotechnologies Inc.

Minneapolis, June 4, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced today it has reached agreement to acquire all of the stock of B-MoGen Biotechnologies Inc. The transaction has been completed and is being financed through available cash on hand. "We are very pleased to include the B-MoGen technology in Bio-Techne's expanding portfolio of products that serve the...

Read More »
Health, Medical, & Dental Supplies and Equipment

Bio-Techne's New Exosome-based Liquid Biopsies Helping to Advance Personalized Care in Lung Cancer Diagnostics

Minneapolis, May 28, 2019 /PRNewswire/ -- Bio-Techne today announced the publication of a recent validation study demonstrating that the proprietary exosome-based liquid biopsy tests from Bio-Techne's Exosome Diagnostics brand may be used to assess the mutational status of the Epidermal Growth Factor Receptor (EGFR) gene in patients with non-small cell lung cancer (NSCLC). The data from...

Read More »

All Topics

COVID-19 Response Suppliers COVID-19 Response:
Can Your Company Help Provide Critical Supplies?

We are using the power of our platform to aid in the mass shortage of critical supplies. If your company can help provide supplies, capabilities, or materials for products such as N-95 Masks and Tyvek SuitsPlease let us know.

COVID-19 Response Suppliers